Authored By: Sarah
26 Oct 2021

Meningococcal Vaccines Market | Leading Segments, Trends, Drivers and Challenges
Market Segments and Growth Analysis 2021-2025

Global meningococcal vaccines market will post an incremental growth of $ 1.68 bn and progressing at a CAGR of  8.94% during the forecast period. Our research report segments the market into major segments and the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus.


Get a peek into our extensive market analysis:  Request for Our FREE Sample Report


Meningococcal Vaccines Market: Leading Segments and Growth Analysis

This research report will provide insights into the current market share of each segment along with growth projections for the next five years.

  • The report segments the market by Geography (North America, Europe, Asia, and ROW). Each market segment is analyzed for past performance leading to future growth projections based on current market scenario.
  • The North America region emerged as the leading segment in recent years. 40% of the market growth will originate from North America during the forecast period. This report provides an accurate prediction of the contribution of all the geographic segments to the growth of the Meningococcal Vaccines Market size.

Meningococcal Vaccines Market Size to Grow by $ 1.68 bn through 2021-2025 | Leading Segments and Market Trends

Meningococcal Vaccines Market: Top Trends, Drivers, Challenges to drive Market Recovery

Our report helps market players to discover the various trends, drivers, and challenges that are likely to influence the market growth during the forecast period. These insights will provide clients with all the information they would require for designing a growth strategy for their business.

  • A significant factor in driving the growth of the Meningococcal Vaccines Market will be the increase in pediatric population.
  • Initiatives from government agencies is another factor that will be instrumental in driving market growth during the forecast period.
  • Slowdown in manufacturing industry is a challenge that needs to be overcome to persist on the path to growth and recovery from the impact of the pandemic.

Meningococcal Vaccines Market: Vendor Analysis

  • The market is fragmented.
  • The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions.
  • Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd.  are some of the major market participants.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The report provides insights into the following FAQs:

  1. What is the market CAGR?
    The market is accelerate at a CAGR of 8.94%.

     
  2. What is the incremental growth of the market?
    The market is expected to grow by $ 1.68 bn through 2021-2025.

     
  3. What is a key factor driving this market?
    Increase in pediatric population will drive market growth over the forecast period.

     
  4. What are the key regions covered in this market research report?
    North America, Europe, Asia, and ROW are the key regions featured in this research report.

     
  5. Which is the leading geographic region for this market:
    40% growth will originate from North America

     
  6. Who are the leading market vendors?
    The leading vendors in this market are Baxter International Inc., Bio-Med Pvt. Ltd., GlaxoSmithKline Plc, Incepta Vaccine Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., and Walvax Biotechnology Co. Ltd. 

     
  7. What are the market segments covered in this report?
    The market is segmented by Geography (North America, Europe, Asia, and ROW)
Read News Read Less
Interested in this report?
Get your sample now!
Technavio
Document